Skip to main content
Clinical Trials/NCT02061150
NCT02061150
Unknown
Not Applicable

Neonatal Sepsis Workup for High Risk Newborns - Evaluation of Need and Ways to Prevent

Hillel Yaffe Medical Center1 site in 1 country800 target enrollmentMarch 2014
ConditionsNeonatal Sepsis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neonatal Sepsis
Sponsor
Hillel Yaffe Medical Center
Enrollment
800
Locations
1
Primary Endpoint
Asymptomatic newborns that underwent sepsis workup
Last Updated
12 years ago

Overview

Brief Summary

Sepsis is a significant cause of morbidity and mortality among newborns. Due to strict criteria and in order to diagnose and prevent early-onset group B streptococcal (EOGBS) sepsis, many infants undergo a sepsis workup due to risk factors alone, even though they are asymptomatic. Our goal is to evaluate the number of newborns that undergo sepsis workup due to risk factors alone, to determine the number of newborns having positive blood cultures, and to establish ways to reduce the number of asymptomatic infants undergoing sepsis workup.

Registry
clinicaltrials.gov
Start Date
March 2014
End Date
June 2015
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Term newborns with blood cultures taken from them the first 48 hrs

Exclusion Criteria

  • Preterm newborns
  • Septic/ill appearing newborns
  • Newborns requiring admission to NICU

Outcomes

Primary Outcomes

Asymptomatic newborns that underwent sepsis workup

Time Frame: 3 years

The number of. asymptomatic newborns that underwent sepsis workup due to maternal risk factors only will be determined

Secondary Outcomes

  • Positive blood cultures out of total cultures(3 years)

Study Sites (1)

Loading locations...

Similar Trials